Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Non-Current Assets (2022 - 2025)

Historic Non-Current Assets for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $4.8 million.

  • Gossamer Bio's Non-Current Assets fell 2692.48% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.4 million, marking a year-over-year increase of 928.99%. This contributed to the annual value of $5.4 million for FY2024, which is 12.97% up from last year.
  • Latest data reveals that Gossamer Bio reported Non-Current Assets of $4.8 million as of Q3 2025, which was down 2692.48% from $5.0 million recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Non-Current Assets ranged from a high of $13.9 million in Q1 2022 and a low of $2.5 million during Q2 2024
  • Its 4-year average for Non-Current Assets is $7.5 million, with a median of $6.4 million in 2023.
  • Its Non-Current Assets has fluctuated over the past 5 years, first tumbled by 6959.38% in 2024, then surged by 9752.46% in 2025.
  • Quarter analysis of 4 years shows Gossamer Bio's Non-Current Assets stood at $10.6 million in 2022, then crashed by 48.94% to $5.4 million in 2023, then rose by 0.13% to $5.4 million in 2024, then fell by 10.6% to $4.8 million in 2025.
  • Its Non-Current Assets was $4.8 million in Q3 2025, compared to $5.0 million in Q2 2025 and $5.1 million in Q1 2025.